162 related articles for article (PubMed ID: 17519236)
1. Promotion of cancer cell migration: an insulin-like growth factor (IGF)-independent action of IGF-binding protein-6.
Fu P; Thompson JA; Bach LA
J Biol Chem; 2007 Aug; 282(31):22298-306. PubMed ID: 17519236
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between MAP kinase pathways is involved in IGF-independent, IGFBP-6-induced Rh30 rhabdomyosarcoma cell migration.
Fu P; Liang GJ; Khot SS; Phan R; Bach LA
J Cell Physiol; 2010 Sep; 224(3):636-43. PubMed ID: 20432455
[TBL] [Abstract][Full Text] [Related]
3. Prohibitin-2 binding modulates insulin-like growth factor-binding protein-6 (IGFBP-6)-induced rhabdomyosarcoma cell migration.
Fu P; Yang Z; Bach LA
J Biol Chem; 2013 Oct; 288(41):29890-900. PubMed ID: 24003225
[TBL] [Abstract][Full Text] [Related]
4. Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding.
Headey SJ; Leeding KS; Norton RS; Bach LA
J Mol Endocrinol; 2004 Oct; 33(2):377-86. PubMed ID: 15525596
[TBL] [Abstract][Full Text] [Related]
5. Endogenous IGFBP-3 is required for both growth factor-stimulated cell proliferation and cytokine-induced apoptosis in mammary epithelial cells.
Leibowitz BJ; Cohick WS
J Cell Physiol; 2009 Jul; 220(1):182-8. PubMed ID: 19259947
[TBL] [Abstract][Full Text] [Related]
6. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
Gallicchio MA; Kaun C; Wojta J; Binder B; Bach LA
J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
[TBL] [Abstract][Full Text] [Related]
7. Differential roles of MAPK-Erk1/2 and MAPK-p38 in insulin or insulin-like growth factor-I (IGF-I) signaling pathways for progesterone production in human ovarian cells.
Seto-Young D; Avtanski D; Varadinova M; Park A; Suwandhi P; Leiser A; Parikh G; Poretsky L
Horm Metab Res; 2011 Jun; 43(6):386-90. PubMed ID: 21448845
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-binding protein-6 produced by human PC-3 prostate cancer cells: isolation, characterization and its biological action.
Srinivasan N; Edwall D; Linkhart TA; Baylink DJ; Mohan S
J Endocrinol; 1996 May; 149(2):297-303. PubMed ID: 8708541
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates growth and IGF-I secretion in human intestinal smooth muscle by Ras-dependent activation of p38 MAP kinase and Erk1/2 pathways.
Kuemmerle JF; Zhou H
J Biol Chem; 2002 Jun; 277(23):20563-71. PubMed ID: 11923300
[TBL] [Abstract][Full Text] [Related]
10. Regulation of vascular smooth muscle cell responses to insulin-like growth factor (IGF)-I by local IGF-binding proteins.
Hsieh T; Gordon RE; Clemmons DR; Busby WH; Duan C
J Biol Chem; 2003 Oct; 278(44):42886-92. PubMed ID: 12917428
[TBL] [Abstract][Full Text] [Related]
11. Ligand-independent activation of the androgen receptor by insulin-like growth factor-I and the role of the MAPK pathway in skeletal muscle cells.
Kim HJ; Lee WJ
Mol Cells; 2009 Dec; 28(6):589-93. PubMed ID: 19937471
[TBL] [Abstract][Full Text] [Related]
12. The role of mitogen-activated protein kinase in insulin and insulin-like growth factor I (IGF-I) signaling cascades for progesterone and IGF-binding protein-1 production in human granulosa cells.
Seto-Young D; Zajac J; Liu HC; Rosenwaks Z; Poretsky L
J Clin Endocrinol Metab; 2003 Jul; 88(7):3385-91. PubMed ID: 12843192
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-binding protein-5 stimulates growth of human intestinal muscle cells by activation of G{alpha}i3.
Flynn RS; Mahavadi S; Murthy KS; Kellum JM; Kuemmerle JF
Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1232-8. PubMed ID: 19808657
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-binding protein-6 and cancer.
Bach LA; Fu P; Yang Z
Clin Sci (Lond); 2013 Feb; 124(4):215-29. PubMed ID: 23126425
[TBL] [Abstract][Full Text] [Related]
15. The N-terminal subdomain of insulin-like growth factor (IGF) binding protein 6. Structure and interaction with IGFs.
Chandrashekaran IR; Yao S; Wang CC; Bansal PS; Alewood PF; Forbes BE; Wallace JC; Bach LA; Norton RS
Biochemistry; 2007 Mar; 46(11):3065-74. PubMed ID: 17305365
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-1 induces MUC8 and MUC5B expression via ERK1 and p38 MAPK in human airway epithelial cells.
Bae CH; Kim JS; Song SY; Kim YW; Park SY; Kim YD
Biochem Biophys Res Commun; 2013 Jan; 430(2):683-8. PubMed ID: 23211593
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells.
Hong J; Zhang G; Dong F; Rechler MM
J Biol Chem; 2002 Mar; 277(12):10489-97. PubMed ID: 11784719
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor I induces proliferation and migration of porcine trophectoderm cells through multiple cell signaling pathways, including protooncogenic protein kinase 1 and mitogen-activated protein kinase.
Jeong W; Song G; Bazer FW; Kim J
Mol Cell Endocrinol; 2014 Mar; 384(1-2):175-84. PubMed ID: 24508636
[TBL] [Abstract][Full Text] [Related]
19. Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor I receptor can be suppressed by dicumarol.
Krause D; Lyons A; Fennelly C; O'Connor R
J Biol Chem; 2001 Jun; 276(22):19244-52. PubMed ID: 11278392
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of insulin-like growth factor binding protein-1 synthesis by interleukin-1beta: requirement of the mitogen-activated protein kinase pathway.
Frost RA; Nystrom GJ; Lang CH
Endocrinology; 2000 Sep; 141(9):3156-64. PubMed ID: 10965886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
